| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |